PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset
Presentation Product Chemical substance Chapter Items dispensed
Xtrasorb HCS dressing 6cm x 6cm square
20031700152
Xtrasorb HCS dressing 6cm x 6cm square Wound Management & Other Dressings Dressings No data available
Xtrasorb Super Absorbent dressing 10.1cm x 12.7cm rectangular
20033000547
Xtrasorb Super Absorbent dressing 10.1cm x 12.7cm rectangular Wound Management & Other Dressings Dressings No data available
Xtrasorb Super Absorbent dressing 10.8cm x 10.8cm square
20033000558
Xtrasorb Super Absorbent dressing 10.8cm x 10.8cm square Wound Management & Other Dressings Dressings No data available
Xtrasorb Super Absorbent dressing 15.2cm x 22.9cm rectangular
20033000548
Xtrasorb Super Absorbent dressing 15.2cm x 22.9cm rectangular Wound Management & Other Dressings Dressings No data available
Xtrasorb Super Absorbent dressing 7.6cm x 7.6cm square
20033000557
Xtrasorb Super Absorbent dressing 7.6cm x 7.6cm square Wound Management & Other Dressings Dressings No data available
Xupad Plus dressing pad 10cm x 12cm
20033000553
Xupad Plus dressing pad 10cm x 12cm Wound Management & Other Dressings Dressings No data available
Xupad Plus dressing pad 10cm x 20cm
20033000554
Xupad Plus dressing pad 10cm x 20cm Wound Management & Other Dressings Dressings No data available
Xupad Plus dressing pad 20cm x 20cm
20033000555
Xupad Plus dressing pad 20cm x 20cm Wound Management & Other Dressings Dressings No data available
Xupad Plus dressing pad 20cm x 40cm
20033000556
Xupad Plus dressing pad 20cm x 40cm Wound Management & Other Dressings Dressings No data available
Xydalba 500mg pdr for concentrate for inf vials
0501070AFBBAAAA
Xydalba Dalbavancin hydrochloride Infections No data available
Xylocaine 0.5% with Adrenaline 100microg/20ml inj vials
1502010J0BBA3A7
Xylocaine (Gel/Injection/Solution) Lidocaine hydrochloride Anaesthesia No data available
Xylocaine Topical 4% solution
1502010J0BBAMAK
Xylocaine (Gel/Injection/Solution) Lidocaine hydrochloride Anaesthesia No data available
Xylonor 150mg/g / 1.5mg/g oromucosal spray
1502010J0BYAAES
Xylonor (Lidocaine hydrochloride) Lidocaine hydrochloride Anaesthesia No data available
Xylotox 2% E80 Dental injection 2.2ml cartridges
1502010J0BJAACQ
Xylotox E80 Lidocaine hydrochloride Anaesthesia No data available
Xyquila 10mg powder for solution for injection vials
040201060BEAAAN
Xyquila Olanzapine Central Nervous System No data available
Xywin 30mg modified-release tablets
0601021M0BRAAAM
Xywin Gliclazide Endocrine System No data available
Y.B. Wet urinal system
22902409046
Y.B. Wet urinal system Urinal Systems Incontinence Appliances No data available
Yakult Light yoghurt drink
090900000BBKBA0
Proprietary compound preparation BNF 0909000 Other food preparations Nutrition and Blood No data available
Yakult yoghurt drink
0913531A0BCAAAB
Yakult liquid OTC probiotic Liquid OTC probiotic (0913531) Nutrition and Blood No data available
Yargesa 100mg capsules
0908010ACBCAAAA
Yargesa Miglustat Nutrition and Blood No data available
Yariba tablets
091200000BFLIA0
Proprietary compound preparation BNF 0912000 Other health supplement preparations Nutrition and Blood No data available
Yarrow flowering tops tincture
190606000BCTUA0
Proprietary compound preparation BNF 1906060 Other tincture preparations Other Drugs and Preparations No data available
Yaz tablets
0703010E0BKAAAF
Yaz Combined ethinylestradiol 20mcg Obstetrics, Gynaecology and Urinary-Tract Disorders No data available
Yeast plasmolysate 4ml/5ml oral solution
091200000AAGDGD
Generic compound preparation BNF 0912000 Other health supplement preparations Nutrition and Blood No data available
Yeast-Vite tablets
0404000D0BGAAA0
Yeast-Vite Caffeine Central Nervous System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.